Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Oncology (Williston Park, N.Y.)
|
June 21, 2019
Breaking New Ground in the Treatment of Advanced Endometrial Cancer
Vicky Makker
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 22, 2020
Getting <i>serious</i> about serous endometrial cancer: should we give chemotherapy in non-invasive cases?
Jennifer Mueller, Vicky Makker
Gynecologic Oncology
|
July 27, 2021
Novel therapy in endometrial cancer: How much will we pay?
Angela K Green, Vicky Makker
Current Opinion in Obstetrics & Gynecology
|
December 14, 2019
Optimizing immunotherapy for gynecologic cancers
Maria M Rubinstein, Vicky Makker
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 28, 2020
A Review of Immune Checkpoint Blockade Therapy in Endometrial Cancer
Angela K Green, Jacqueline Feinberg, Vicky Makker
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
From Burnout to Resilience: An Update for Oncologists
Krithika Murali, Vicky Makker, James Lynch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 20, 2013
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009
Vicky Makker, Martee L Hensley, Qin Zhou, et al.
Gynecologic Oncology Reports
|
August 25, 2021
Sustained response to lenvatinib and pembrolizumab in two patients with <i>KRAS</i>-mutated endometrial mesonephric-like adenocarcinoma
Sherry Shen, Maria M Rubinstein, Kay J Park, et al.
Gynecologic Oncology Reports
|
April 24, 2019
Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
Maria Rubinstein, Darragh Halpenny, Vicky Makker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 15, 2023
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A Zammarrelli, Eric V Rios-Doria, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Oncology (Williston Park, N.Y.)
|
June 21, 2019
Breaking New Ground in the Treatment of Advanced Endometrial Cancer
Vicky Makker
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 22, 2020
Getting <i>serious</i> about serous endometrial cancer: should we give chemotherapy in non-invasive cases?
Jennifer Mueller, Vicky Makker
Gynecologic Oncology
|
July 27, 2021
Novel therapy in endometrial cancer: How much will we pay?
Angela K Green, Vicky Makker
Current Opinion in Obstetrics & Gynecology
|
December 14, 2019
Optimizing immunotherapy for gynecologic cancers
Maria M Rubinstein, Vicky Makker
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
March 28, 2020
A Review of Immune Checkpoint Blockade Therapy in Endometrial Cancer
Angela K Green, Jacqueline Feinberg, Vicky Makker
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
September 21, 2018
From Burnout to Resilience: An Update for Oncologists
Krithika Murali, Vicky Makker, James Lynch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 20, 2013
Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009
Vicky Makker, Martee L Hensley, Qin Zhou, et al.
Gynecologic Oncology Reports
|
August 25, 2021
Sustained response to lenvatinib and pembrolizumab in two patients with <i>KRAS</i>-mutated endometrial mesonephric-like adenocarcinoma
Sherry Shen, Maria M Rubinstein, Kay J Park, et al.
Gynecologic Oncology Reports
|
April 24, 2019
Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
Maria Rubinstein, Darragh Halpenny, Vicky Makker, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 15, 2023
Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Sushmita Gordhandas, William A Zammarrelli, Eric V Rios-Doria, et al.
Page
of 14